Patents by Inventor Yukio Kamijo

Yukio Kamijo has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 4632934
    Abstract: The imidazole derivatives of the formula: ##STR1## wherein R is a hydrogen atom or an alkyl group, A.sub.1 and A.sub.2, which may be the same or different, each is an alkylene or an alkylene group, m is 0 or 1, and Z is ##STR2## wherein R.sub.1 and R.sub.2, which may be the same or different, each is a hydrogen atom or an alkyl group, and the terminal carbon atom bonded to the hetero atom of Z may be bonded to either A.sub.1 or A.sub.2 or COOR group (in the case of m being 0); and the pharmaceutically acceptable salts thereof. These compounds have a strong inhibitory effect on thromboxane synthetase from human or bovine platelet microsomes, and are useful as therapeutically actives for inflammation, hypertension, thrombus, cerebral apoplexy and asthma.
    Type: Grant
    Filed: August 21, 1979
    Date of Patent: December 30, 1986
    Assignees: Kissei Pharmaceutical Co., Ltd., Ono Pharmaceutical Co., Ltd.
    Inventors: Kinji Iizuka, Keniji Akahane, Denichi Momose, Yukio Kamijo, Yukiyoshi Ajisawa
  • Patent number: 4320134
    Abstract: The imidazole compounds of the general formula (I): ##STR1## wherein Y is a carboxyl group, a hydroxymethyl group, an N-di or -mono alkyl substituted or unsubstituted carbamoyl group, a cyano group, or an N-di or -mono alkyl substituted or unsubstituted aminomethyl group, and n is an integer of 3 to 20; and pharmaceutically acceptable salts thereof. These compounds have a strong inhibitory effect on thromboxane synthetase from rabbit platelet microsomes, and are useful as therapeutically active agents for inflammation, hypertension, thrombus, cerebral apoplexy and asthma.
    Type: Grant
    Filed: February 21, 1979
    Date of Patent: March 16, 1982
    Assignees: Ono Pharmaceutical Co., Ltd., Kissei Pharmaceutical Co., Ltd.
    Inventors: Kinji Iizuka, Kenji Akahane, Yukio Kamijo, Denichi Momose, Yukiyoshi Ajisawa
  • Patent number: 4226878
    Abstract: Novel imidazole derivatives of the general formula (I): ##STR1## wherein Y is a carboxyl group, an alkoxycarbonyl group, a cyano group, a hydroxymethyl group, an aminomethyl group, a formyl group or a carbamoyl group, and A and B, which may be the same or different, each is a straight- or branched-chain alkylene or alkenylene group, and n and m, which may be the same or different, each is zero or 1, with the proviso that when A is methylene group or n is zero, m is 1; and pharmaceutically acceptable salts thereof. These compounds have a strong inhibitory effect on thromboxane synthetase from rabbit platelet microsomes, and are useful as therapeutically active agents for the treatment of inflammation, hypertension, thrombus, cerebral apoplexy and asthma.
    Type: Grant
    Filed: June 13, 1979
    Date of Patent: October 7, 1980
    Assignees: Kissei Pharmaceutical Co., Ltd., Ono Pharmaceutical Co., Ltd.
    Inventors: Kinji Iizuka, Kenji Akahane, Denichi Momose, Yukio Kamijo, Yukiyoshi Ajisawa